High Vitamin D Levels May Downregulate Inflammation in Patients with Behçet's Disease

Vitamin D plays a significant role in the immune system modulation and may confer a protective role in autoimmune diseases. We conducted a case-control study to compare 25(OH)D levels in patients with BD who were managed at a regional rheumatology programme in the midwest region of Ireland compared...

Full description

Bibliographic Details
Main Authors: Adeeb, F. (Author), Devlin, J. (Author), Fraser, A.D (Author), Khan, M.U (Author), Li, X. (Author), Stack, A.G (Author)
Format: Article
Language:English
Published: Hindawi Limited 2017
Subjects:
Online Access:View Fulltext in Publisher
View in Scopus
LEADER 02824nam a2200385Ia 4500
001 10.1155-2017-8608716
008 220120s2017 CNT 000 0 und d
020 |a 20908040 (ISSN) 
245 1 0 |a High Vitamin D Levels May Downregulate Inflammation in Patients with Behçet's Disease 
260 0 |b Hindawi Limited  |c 2017 
520 3 |a Vitamin D plays a significant role in the immune system modulation and may confer a protective role in autoimmune diseases. We conducted a case-control study to compare 25(OH)D levels in patients with BD who were managed at a regional rheumatology programme in the midwest region of Ireland compared to matched controls. Healthy controls were selected from the Irish health system and matched in 1: 5 ratio for age, sex, and the month of the year. 25(OH)D levels <20 nmol/L were classified as deficient while levels between 20 and 40 nmol/L were classified as insufficient. Differences between groups were assessed using Mann-Whitney test and associations between cases and controls were expressed as odds ratios and 95% confidence intervals. Nineteen patients with BD were compared with 95 controls matched by age, sex, and month of blood draw. 25(OH)D levels were significantly higher in patients in BD than in matched controls (median values: 45 nmol/L versus 22 nmol/L, p<0.005) and tended to be lower in patients with active disease than in those without (median values: 35 nmol/L (IQR: 22.75-47.25 nm/L) versus 50 nmol/L (IQR: 35-67 nmol/L), p=0.11). Compared to controls, patients with BD were significantly less likely to have 25(OH)D deficiency or insufficiency (OR: 0.09, 95% CI: 0.03-0.28, p<0.001). Our findings suggest a possible role for 25(OH)D in modifying the inflammatory response in BD and uncover a potential opportunity to assess whether correction of Vit D deficiency confers protective benefits. © 2017 Fahd Adeeb et al. 
650 0 4 |a 25 hydroxyvitamin D 
650 0 4 |a adult 
650 0 4 |a Behcet disease 
650 0 4 |a case control study 
650 0 4 |a Caucasian 
650 0 4 |a clinical article 
650 0 4 |a Conference Paper 
650 0 4 |a controlled study 
650 0 4 |a down regulation 
650 0 4 |a female 
650 0 4 |a human 
650 0 4 |a inflammation 
650 0 4 |a Ireland 
650 0 4 |a male 
650 0 4 |a vitamin blood level 
700 1 0 |a Adeeb, F.  |e author 
700 1 0 |a Devlin, J.  |e author 
700 1 0 |a Fraser, A.D.  |e author 
700 1 0 |a Khan, M.U.  |e author 
700 1 0 |a Li, X.  |e author 
700 1 0 |a Stack, A.G.  |e author 
773 |t International Journal of Inflammation  |x 20908040 (ISSN)  |g 2017 
856 |z View Fulltext in Publisher  |u https://doi.org/10.1155/2017/8608716 
856 |z View in Scopus  |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-85021630467&doi=10.1155%2f2017%2f8608716&partnerID=40&md5=fa1d842c39901d0db40d225ba18c027a